help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vorwerk, P.
Right arrow Articles by Shymko, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vorwerk, P.
Right arrow Articles by Shymko, R. M.
Endocrinology Vol. 143, No. 5 1677-1685
Copyright © 2002 by The Endocrine Society


GROWTH FACTORS-CYTOKINES-ONCOGENES

Binding Properties of Insulin-Like Growth Factor Binding Protein-3 (IGFBP-3), IGFBP-3 N- and C-Terminal Fragments, and Structurally Related Proteins mac25 and Connective Tissue Growth Factor Measured Using a Biosensor

Peter Vorwerk, Bianka Hohmann, Youngman Oh, Ron G. Rosenfeld and Ronald M. Shymko

Department of Pediatric Oncology, Otto von Guericke University (P.V., B.H.), Magdeburg 39112, Germany; Department of Pediatrics, Oregon Health Sciences University (Y.O., R.G.R.), Portland, Oregon 97201; and Department of Scientific Computing, Novo Nordisk A/S (R.M.S.), Måløv DK-2760, Denmark

Address all correspondence and requests for reprints to: Dr. Peter Vorwerk, M.D., Department of Pediatric Oncology, Otto von Guericke University, Emanuel Larisch Weg 17-19, D-39112 Magdeburg, Germany. E-mail: . peter.vorwerk{at}medizin.uni-magdeburg.de

We measured the binding of IGF-I and IGF-II to recombinant human N-terminal [residues 1–97; recombinant human IGF-binding protein-31–97 (rhIGFBP-31–97)] and C-terminal (residues 98–264; rhIGFBP-398–264) IGFBP-3 fragments and compared it with IGF binding to intact IGFBP-3 using biosensor analysis. Experiments were carried out in different configurations, either with binding protein or fragment immobilized or with IGF immobilized. These experiments showed that IGF-I and IGF-II bind to IGFBP-3 with affinities of 4–5 x 109 M-1 and similar binding kinetics. The affinities of both rhIGFBP-31–97 and rhIGFBP-398–264 for IGF proteins were approximately 3 orders of magnitude less than that of full-length IGFBP-3. These results further support the concept that high affinity binding of IGF to IGF-binding proteins results from a two-site interaction of IGF with both the N- and C-terminal regions of the binding protein.

Binding of insulin to IGFBP-3 and its N- and C-terminal fragments and of IGF-I and IGF-II to the structurally related proteins mac25 and connective tissue growth factor was also investigated. Weak insulin binding to full-length IGFBP-3 could be demonstrated in a few experiments, but we found that binding of IGF-I, IGF-II, and insulin to mac25 or connective tissue growth factor was below the detection limit of the biosensor instrument.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Sitar, G. M. Popowicz, I. Siwanowicz, R. Huber, and T. A. Holak
Structural basis for the inhibition of insulin-like growth factors by insulin-like growth factor-binding proteins
PNAS, August 29, 2006; 103(35): 13028 - 13033.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. Lopez-Bermejo, J. Khosravi, J. M. Fernandez-Real, V. Hwa, K. L. Pratt, R. Casamitjana, M. M. Garcia-Gil, R. G. Rosenfeld, and W. Ricart
Insulin Resistance Is Associated With Increased Serum Concentration of IGF-Binding Protein-Related Protein 1 (IGFBP-rP1/MAC25).
Diabetes, August 1, 2006; 55(8): 2333 - 2339.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. J. Allan, E. Tonner, M. Szymanowska, J. H. Shand, S. M. Kelly, K. Phillips, R. A. Clegg, I. F. Gow, J. Beattie, and D. J. Flint
Cumulative Mutagenesis of the Basic Residues in the 201-218 Region of Insulin-Like Growth Factor (IGF)-Binding Protein-5 Results in Progressive Loss of Both IGF-I Binding and Inhibition of IGF-I Biological Action
Endocrinology, January 1, 2006; 147(1): 338 - 349.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
J. Beattie, K. Phillips, J. H Shand, M. Szymanowska, D. J Flint, and G. J Allan
Molecular recognition characteristics in the insulin-like growth factor (IGF)-insulin-like growth factor binding protein -3/5 (IGFBP-3/5) heparin axis
J. Mol. Endocrinol., February 1, 2005; 34(1): 163 - 175.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
S. J Headey, K. S Leeding, R. S Norton, and L. A Bach
Contributions of the N- and C-terminal domains of IGF binding protein-6 to IGF binding
J. Mol. Endocrinol., October 1, 2004; 33(2): 377 - 386.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. Lam, R. N. van der Geest, N. A.M. Verhagen, F. A. van Nieuwenhoven, I. E. Blom, J. Aten, R. Goldschmeding, M. R. Daha, and C. van Kooten
Connective Tissue Growth Factor and IGF-I Are Produced by Human Renal Fibroblasts and Cooperate in the Induction of Collagen Production by High Glucose
Diabetes, December 1, 2003; 52(12): 2975 - 2983.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Lopez-Bermejo, J. Khosravi, C. L. Corless, R. G. Krishna, A. Diamandi, U. Bodani, E. M. Kofoed, D. L. Graham, V. Hwa, and R. G. Rosenfeld
Generation of Anti-Insulin-Like Growth Factor-Binding Protein-Related Protein 1 (IGFBP-rP1/MAC25) Monoclonal Antibodies and Immunoassay: Quantification of IGFBP-rP1 in Human Serum and Distribution in Human Fluids and Tissues
J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3401 - 3408.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. D. Payet, X.-H. Wang, R. C. Baxter, and S. M. Firth
Amino- and Carboxyl-Terminal Fragments of Insulin-Like Growth Factor (IGF) Binding Protein-3 Cooperate to Bind IGFs with High Affinity and Inhibit IGF Receptor Interactions
Endocrinology, July 1, 2003; 144(7): 2797 - 2806.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. H. Shand, J. Beattie, H. Song, K. Phillips, S. M. Kelly, D. J. Flint, and G. J. Allan
Specific Amino Acid Substitutions Determine the Differential Contribution of the N- and C-terminal Domains of Insulin-like Growth Factor (IGF)-binding Protein-5 in Binding IGF-I
J. Biol. Chem., May 9, 2003; 278(20): 17859 - 17866.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2002 by The Endocrine Society